Edited by Arthur A. Sasahara and Joseph Loscalzo. 681 pp., illustrated. New York, Marcel Dekker, 1997. $195. ISBN 0-8247-9866-X.
Despite remarkable progress in the past two decades in preventingmyocardial infarction and stroke, the thrombotic complicationsof the atherosclerotic process are still a leading cause ofmorbidity and mortality. The demonstration that streptokinase,a thrombolytic agent, and low-dose aspirin, an antiplateletagent, can each reduce mortality from vascular causes by aboutone quarter when administered early in the course of an acutemyocardial infarction, and that their separate benefits areadditive when the two drugs are given together, has dramaticallychanged the life expectancy of patients with myocardial infarctionand provides compelling evidence that coronary thrombosis isa dynamic, . . . [Full Text of this Article]
Previous
